FDA

Use of Social Media in Healthcare

Trendspotting with Kristen Smithwick There’s been plenty of talk in recent months about the impact of social media on the future of healthcare. Many stakeholders are carving out their own space within the social media sphere, with customized strategies that fit their respective ambitions and external pressures, such as regulatory guidelines. Biopharmaceutical companies are beginning …

Use of Social Media in Healthcare Read More »

Reflections on SMi Knowledge Leader Conference

Neil Mellor, business development consultant at Thought Leader Select, and Paul Meade, the company’s president and founder, attended SMi’s KOL: Knowledge Leader Partnerships conference on September 29 and 30 in London.  Neil sat down with the Thought Leader Select Blog to discuss his takeaways from the conference. TLS Blog:  Neil, how was the conference in …

Reflections on SMi Knowledge Leader Conference Read More »

Fast Facts from Thought Leader Select—Trends in Diabetes Advocacy Involvement

Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their advice and guidance in the development of new medicines. Over the past several years, Thought …

Fast Facts from Thought Leader Select—Trends in Diabetes Advocacy Involvement Read More »

Fast Facts from Thought Leader Select–Payer KOLs

Key opinion leaders (KOLs) are health care leaders who make a high-impact footprint while advancing medical science. Thought Leader Select specializes in delivering objective, validated data on the skills and experiences of KOLs, so that pharmaceutical companies can seek their appropriate advice and guidance in the development of new medicines. Thought Leader Select measures many …

Fast Facts from Thought Leader Select–Payer KOLs Read More »

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part Two

KOLs Provide the “Voice of the Patient” for Life-changing Discoveries According to the Pharmaceutical Research and Manufacturers of America (PhRMA—(http://www.phrma.org/), “Only one of every 10,000 potential medicines investigated by America’s research-based pharmaceutical companies makes it through the research and development pipeline and is approved for patient use by the United States Food and Drug Administration.” …

The Trifecta of Mutually-Beneficial Relationships: KOLs, Pharma and Patients—Part Two Read More »